Advance your treatment to the patients who need it most with clinical research support from our therapeutically aligned, highly specialized experts. We have in-depth knowledge and years of experience in infectious disease research from around the world, allowing us to bring you exceptional personalized experiences no matter where we join you in your journey.
Our flexible teams have a deep understanding and expertise in conducting clinical trials for infectious diseases including COVID-19. Our scientists and clinicians have extensive experience with related treatments including vaccines, antivirals, antibiotics and antifungal compounds, making them well equipped to offer the guidance that moves your trials forward.
We have the agility, capacity, and processes in place to mobilize quickly and support start-up, site onboarding and enrollment for acute diseases even during peak seasons. We anticipate challenges as we help you navigate evolving regulations, operational complexities and tight timelines.
With comprehensive services from study start-up and feasibility studies to market applications and access to a global network of sites and cohorts, we help you select the right place and the right patients for your clinical research.
Where your infectious disease study requires analysis of genomic, proteomic, transcriptomic, metabolomic and other “omics” data, our bioanalytical experts take ownership of the analysis, monitoring and reporting of your data so you can make the right decisions at the right time.
We remain therapeutically aligned with your treatment. Your project will be designed and led by a clinician who understands the clinical settings and patient archetypes involved in infectious disease studies. Our dedicated and transparent team will coordinate all aspects of your program from end to end, through regulatory consultation, innovative monitoring, and visual analytics to deliver the highest quality data you need to advance your therapy.
Our expertise expands beyond research sites, connecting with hospitals and outpatient settings to help you start your trials quickly and get the results you need.
We are fully invested in the outcomes of your trials, providing the resources and expertise when and how you need them and sharing therapeutic area expertise and knowledge to help you make the best decisions.
Led by scientific experts, our team understands the nuances of your nephrology studies in both rare and non-rare indications.
Our respiratory experience in both clinical practice and pharmaceutical R&D enables us to deliver ...
We help activate the full potential of your scientific breakthroughs and overcome the challenges in ...
Our experts have deep expertise and understanding of the unique healthcare needs for women, partnering ...
Get your scientific breakthroughs in gastroenterology to the right patients with exceptional personalized clinical research ...
Partner with a CRO who understands your infectious disease area and has the experience to advance your innovation through clinical trials and beyond.
Explore our news and updates as we liberate the clinical research process.
MORRISVILLE, N.C., November 9, 2022 – Caidya, the multi-therapeutic clinical research organization (CRO) focused on delivery excellence and an elevated customer experience, announced today the appointment ...
SHANGHAI and MORRISVILLE, N.C., October 3, 2022 – dMed | Clinipace, ...
SHANGHAI, CHINA and MORRISVILLE, NORTH CAROLINA, USA, April 28, 2021 – ...